BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36086675)

  • 1. Effect of pembrolizumab on T lymphocyte subsets in patients with advanced oral cancer and its therapeutic effect.
    Feng L; Li TK; Yin K; Zhang SX; Chen Z; Bao Y
    Medicine (Baltimore); 2022 Sep; 101(36):e30534. PubMed ID: 36086675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Pembrolizumab on T Lymphocyte Subsets in Patients with Advanced 
Non-small Cell Lung Cancer and Its Therapeutic Effect].
    Wang Y; Wang Y; Jiang M; Zhao Y; Zhang X
    Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):182-187. PubMed ID: 33819968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in T lymphocyte subsets predict the efficacy of atezolizumab in advanced non-small cell lung cancer: a retrospective study.
    Wang Y; Zhu J; Zhou N; Wang Y; Zhang X
    J Thorac Dis; 2023 Oct; 15(10):5669-5679. PubMed ID: 37969284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A therapy that modulates T lymphocyte subsets in patients infected with Epstein-Barr virus: Ganciclovir combined with interferon atomization inhalation.
    Ren Q; Feng Y
    Medicine (Baltimore); 2023 Aug; 102(34):e34946. PubMed ID: 37653833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
    Yan Y; Wang X; Liu C; Jia J
    BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of lymphocyte subsets with the efficacy and prognosis of PD‑1 inhibitor therapy in advanced gastric cancer: results from a monocentric retrospective study.
    Wang X; Liu X; Dai H; Jia J
    BMC Gastroenterol; 2024 Mar; 24(1):113. PubMed ID: 38491354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes of T Lymphocyte Subsets and Immunoglobulin in Peripheral Blood of Patients with ALL and N-ALL before and after Treatment and their Value for Monitoring of Disease and Evaluation of Prognosis].
    Zhu QY; Dian ZJ; Zhou YG; Zhao Z; Zhang Z; Zhang XY; Yang BR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):136-140. PubMed ID: 29397832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of T lymphocyte subset changes after first line chemotherapy in peripheral blood from patients with advanced stage adenocarcinoma cell lung cancer].
    Yan X; Zhao X; Jiao S; Sun S; Wu L; Wu Z
    Zhongguo Fei Ai Za Zhi; 2012 Mar; 15(3):164-71. PubMed ID: 22429580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
    Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
    Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of traumatic severity with change in lymphocyte subsets in the early stage after trauma].
    Hua R; Chen FX; Zhang YM; Zhou ZH; Wang SJ; Liang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Aug; 25(8):489-92. PubMed ID: 24021046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy.
    Murta EF; de Andrade JM; Falcão RP; Bighetti S
    Tumori; 2000; 86(5):403-7. PubMed ID: 11130570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
    Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
    Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression analysis of lymphocyte subsets and lymphocyte-to-monocyte ratio: reveling immunosuppression and chronic inflammation in breast cancer.
    Zhang H; Li Y; Liu G; Chen X
    J Cancer Res Clin Oncol; 2024 Jan; 150(1):28. PubMed ID: 38263363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of Lymphocyte Subsets in Peripheral Blood of Patients with Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome].
    Lv YF; Yan ZY; Chen NY; Wu JH; Liu B; Wang GL; Wang J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1505-1510. PubMed ID: 27784383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between peripheral blood lymphocyte subsets and clinical outcomes in patients with lung cancer treated with immune checkpoint inhibitor.
    Li P; Qin P; Fu X; Zhang G; Yan X; Zhang M; Zhang X; Yang J; Wang H; Ma Z
    Ann Palliat Med; 2021 Mar; 10(3):3039-3049. PubMed ID: 33849094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing Reference Values for Peripheral Blood Lymphocyte Subsets of Healthy Children in China Using a Single Platform.
    Zhang L; Zhong H; Wei B; Fan J; Huang J; Li Y; Liu W
    J Immunol Res; 2022; 2022():5603566. PubMed ID: 36033395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between T lymphocyte subsets and different syndrome types in patients with influenza A (H1N1): a retrospective study].
    Huang Y; Zeng X; Zhu W; Li SS; Zhou D; Lu CJ
    Zhong Xi Yi Jie He Xue Bao; 2011 Feb; 9(2):143-7. PubMed ID: 21288448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Distribution of peripheral blood lymphocyte subsets in 826 healthy children aged 0-6 years].
    Zhan WL; Yang XH; Guo H; Zhong ZC; DU QY; Zhang CB; Huang BM; Liu H; Luo MY
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Feb; 21(2):180-183. PubMed ID: 30782284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates.
    Liao JB; Gwin WR; Urban RR; Hitchcock-Bernhardt KM; Coveler AL; Higgins DM; Childs JS; Shakalia HN; Swensen RE; Stanton SE; Tinker AV; Wahl TA; Ancheta RG; McGonigle KF; Dai JY; Disis ML; Goff BA
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.